Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6


Cutting Edge: Tumor-specific CD8+ T cells infiltrating prostatic tumors are induced to become suppressor cells.

Shafer-Weaver KA, Anderson MJ, Stagliano K, Malyguine A, Greenberg NM, Hurwitz AA.

J Immunol. 2009 Oct 15;183(8):4848-52. doi: 10.4049/jimmunol.0900848.


Transforming growth factor-beta-induced regulatory T cells referee inflammatory and autoimmune diseases.

Wahl SM, Chen W.

Arthritis Res Ther. 2005;7(2):62-8. Epub 2005 Jan 24. Review.


T cell tolerance to tumors and cancer immunotherapy.

Shafer-Weaver K, Anderson M, Malyguine A, Hurwitz AA.

Adv Exp Med Biol. 2007;601:357-68. Review.


Regulatory T cell: a protection for tumour cells.

Wang Y, Ma Y, Fang Y, Wu S, Liu L, Fu D, Shen X.

J Cell Mol Med. 2012 Mar;16(3):425-36. doi: 10.1111/j.1582-4934.2011.01437.x. Review.


Releasing the brake: targeting Cbl-b to enhance lymphocyte effector functions.

Wallner S, Gruber T, Baier G, Wolf D.

Clin Dev Immunol. 2012;2012:692639. doi: 10.1155/2012/692639. Epub 2012 Apr 10. Review.


Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication.

Quezada SA, Peggs KS, Simpson TR, Allison JP.

Immunol Rev. 2011 May;241(1):104-18. doi: 10.1111/j.1600-065X.2011.01007.x. Review.

Supplemental Content

Support Center